The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study to evaluate the safety and tolerability of MEDI4736, an anti- programmed cell death-ligand-1 (PD-L1) antibody, in combination with tremelimumab in patients with advanced solid tumors.
 
Patrick Alexander Ott
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - ARMO BioSciences; Bristol-Myers Squibb; Merck
 
Margaret K. Callahan
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Kyowa Hakko Kirin
Research Funding - Bristol-Myers Squibb (Inst)
 
Kunle Odunsi
No Relationships to Disclose
 
Andrew J. Park
Employment - Theradex
Research Funding - MedImmune (Inst)
 
Linda S. Pan
No Relationships to Disclose
 
Ralph Rudolph Venhaus
Stock and Other Ownership Interests - Agenus; Dynavax Technologies; Soligenix
 
Joyson Joseph Karakunnel
Employment - Suburban Hosptial
Patents, Royalties, Other Intellectual Property - MedImmune
Travel, Accommodations, Expenses - MedImmune
Other Relationship - MedImmune
 
F. Stephen Hodi
Consulting or Advisory Role - Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Potenza Therapeutics; Vesuvius Pharmaceuticals
Honoraria - EMD Serono; Janssen Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Jounce Therapeutics; MedImmune; Merck; Polaris; Polynoma; ZIOPHARM Oncology
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Bristol-Myers Squibb